Harvard Bioscience, Inc. (HBIO)
0.7492
+0.01
(+0.81%)
USD |
NASDAQ |
Dec 12, 16:00
0.70
-0.05
(-6.57%)
After-Hours: 18:28
Harvard Bioscience Research and Development Expense (Quarterly): 2.132M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Bruker Corp. | 98.30M |
| Azenta, Inc. | 8.258M |
| Precipio, Inc. | -- |
| Bionano Genomics, Inc. | 2.844M |
| Kestra Medical Technologies Ltd. | 4.001M |